Read + Share
Amedeo Smart
Independent Medical Education
Diamantopoulos PT, Kontandreopoulou CN, Stafylidis C, Vlachopoulou D, et al. Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection. Ann Hematol 2022;101:2711-2717.PMID: 36271935
Email
LinkedIn
Facebook
Twitter
Privacy Policy